U.S. influenza activity is at its highest level in at least 15 years, with significant rise in reported cases leading to numerous hospitalizations and deaths, according to the CDC.
SYMBRAVO (meloxicam and rizatriptan) has received U.S. Food and Drug Administration approval for the acute treatment of migraine with or without aura in adults.
Enhertu, a HER2-directed antibody-drug conjugate, was approved by the U.S. Food and Drug Administration for pretreated patients with metastatic HR-positive, HER2-low or HER2-ultralow breast cancer based on results from the DESTINY-Breast06 trial.
“Each subsequent infection could potentially increase the burden on the immune system, leaving individuals vulnerable to the cumulative effects of the virus."
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
“You are instilling fear into folks who may defer care, who may go without care, whose children may not get the vaccines they need, who may not be able to get treatment for an ear infection or surgery."
President Donald Trump announces the withdrawal of the United States from the World Health Organization, prompting concern about the impact on global health programs and funding.
NIH director, Dr. Monica M. Bertagnolli, is stepping down after launching major initiatives in women's health and long COVID research, indicating optimism for their continuation under new leadership.